立方製藥(003020.SZ):信德匯金及廣遠眾合減持期滿 已減持1.69%股份、後續擬清倉減持合計不超0.3%股份
格隆匯8月1日丨立方製藥(003020.SZ)公佈,公司股東廣發信德中恒匯金(龍巖)股權投資合夥企業(有限合夥)(簡稱“信德匯金”)及其員工跟投平台廣遠眾合(珠海)投資企業(有限合夥)(簡稱“廣遠眾合”)減持計劃期限屆滿,在計劃期限內信德匯金減持公司股份2,181,900股,佔公司佔總股本的1.62%;廣遠眾合減持公司股份104,500股,佔公司總股本的0.07%。
信德匯金及廣遠眾合計劃自公吿披露之日起3個交易日後的六個月內以集中競價方式、大宗交易方式或協議轉讓方式減持公司股份不超過477,157股,即不超過公司總股本的0.30%(若此期間有送股、資本公積金轉增股本等股份變動事項,應對該數量進行相應處理)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.